Cencora, Inc. (COR)
Data as of , from SEC Form 4 filings.
See up to 3 months of COR. The 7-day demo opens the 1M and 3M ranges and puts COR on your watchlist.
Start 7-day demoLatest COR insider trades
About Cencora, Inc. (COR)
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
- CONSHOHOCKEN, PA
- 51,000
- 1995
- XNYS
COR Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 4 | 14,551 | $4.69M |
| Grant or award | 4 | 582 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
COR insider transactions (Form 4)
40109 Form 4 filings on record, the earliest from Oct 23, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Robert E. Sanchez - Director | Grant or award | Common Stock | 275 | - footnote F2 | - | |
| ||||||
| Lazarus Krikorian - Officer | Open-market sale | Common Stock | 986 | $303.18 | $299K | |
| Lon R. Greenberg - Director | Open-market sale | Common Stock | 1,280 | $321.30 | $411K | |
| Lazarus Krikorian - Officer | Open-market sale | Common Stock | 985 footnote F1 | $325.97 | $321K | |
| ||||||
 Elizabeth S. Campbell - Officer | Open-market sale | Common Stock | 11,300 | $324.12 footnote F1 | $3.66M | |
| ||||||
| Dennis M. Nally - Director | Grant or award | Common Stock | 113 | $311.34 | $35K | |
| Ellen Cooper - Director | Grant or award | Common Stock | 97 | $311.34 | $30K | |
 Lauren M. Tyler - Director | Grant or award | Common Stock | 97 | $311.34 | $30K | |
 Silvana Battaglia - Officer | Grant or award | Common Stock | 58.2 footnote F1 | $240.53 | $14K | |
| ||||||
| Elizabeth S. Campbell - Officer | Grant or award | Common Stock | 49.89 footnote F1 | $240.53 | $12K | |
| ||||||
| Eva C. Boratto - Officer | Grant or award | Restricted Stock Units | 21,304 | - footnote F1 | - | |
| ||||||
| Lauren M. Tyler - Director | Open-market purchase | Common Stock | 550 | $270.23 | $149K | |
| Dermot Mark Durcan - Director | Open-market purchase | Common Stock | 4,000 | $274.19 | $1.10M | |
| Dermot Mark Durcan - Director | Open-market purchase | Common Stock | 4,000 | $266.26 | $1.07M | |
| Lauren M. Tyler - Director | Grant or award | Common Stock | 99 | $304.00 | $30K | |
| Ellen Cooper - Director | Grant or award | Common Stock | 99 | $304.00 | $30K | |
| Dennis M. Nally - Director | Grant or award | Common Stock | 116 | $304.00 | $35K | |
| Lazarus Krikorian - Officer | Grant or award | Restricted Stock Units | 3,936 | $0.00 | - | |
| Silvana Battaglia - Officer | Option exercise | Restricted Stock Units | 8,415 | $0.00 | - | |
| Silvana Battaglia - Officer | Option exercise | Common Stock | 8,415 | $0.00 footnote F1 | - | |
| Silvana Battaglia - Officer | Tax withholding / forfeiture | Common Stock | 3,673 | $350.30 | $1.29M | |
| ||||||
| Elizabeth S. Campbell - Officer | Option exercise | Common Stock | 12,623 | $0.00 footnote F1 | - | |
| Elizabeth S. Campbell - Officer | Tax withholding / forfeiture | Common Stock | 5,842 | $350.30 | $2.05M | |
| Elizabeth S. Campbell - Officer | Option exercise | Restricted Stock Units | 12,623 | $0.00 | - | |
| ||||||
| James F. Cleary - Officer | Option exercise | Restricted Stock Units | 12,623 | $0.00 | - | |
| James F. Cleary - Officer | Option exercise | Common Stock | 12,623 | $0.00 footnote F1 | - | |
| James F. Cleary - Officer | Tax withholding / forfeiture | Common Stock | 5,409 | $350.30 | $1.89M | |
| ||||||
| Ellen Cooper - Director | Grant or award | Common Stock | 69 | $359.22 | $25K | |
| Ellen Cooper - Director | Grant or award | Common Stock | 66 | $359.22 | $24K | |
| Ellen Cooper - Director | Grant or award | Common Stock | 557 | $359.28 | $200K | |
| Dennis M. Nally - Director | Grant or award | Common Stock | 98 | $359.22 | $35K | |
| Dennis M. Nally - Director | Grant or award | Common Stock | 557 | $359.28 | $200K | |
| Lauren M. Tyler - Director | Grant or award | Common Stock | 84 | $359.22 | $30K | |
| Lauren M. Tyler - Director | Grant or award | Common Stock | 557 | $359.28 | $200K | |
 Werner Baumann - Director | Grant or award | Common Stock | 557 | $359.28 | $200K | |
| Frank Clyburn - Director | Grant or award | Common Stock | 557 | $359.28 | $200K | |
| Dermot Mark Durcan - Director | Grant or award | Common Stock | 905 | $359.28 | $325K | |
| Lon R. Greenberg - Director | Grant or award | Common Stock | 557 | $359.28 | $200K | |
 Lorence H. Kim - Director | Grant or award | Common Stock | 557 | $359.28 | $200K | |
| Redonda Miller - Director | Grant or award | Common Stock | 557 | $359.28 | $200K | |
Recent COR Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Lon Greenberg | Director | 1,280 | $411K | View on EDGAR | |
| Battaglia Silvana | Former Officer | 1,324 |
Stock trades in COR disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Jared MoskowitzDemocrat, FL-23 | Sale |
COR insider trading FAQ
What is the latest insider trade for COR?
Cencora, Inc. (COR) had 8 insider filings in the last 90 days, with the most recent on 2026-10-05. The full record for COR runs to 109 Form 4 filings, the earliest from 2024-10-23. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying COR stock?
No insider purchases of COR were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling COR stock?
4 insider sales of COR were filed in the last 90 days, totaling $4.69M.
Where can I see COR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects COR Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Consumer Staples companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Robert E. Sanchez view on EDGAR
- - Lazarus Krikorian view on EDGAR
- - Lon R. Greenberg view on EDGAR
- - Lazarus Krikorian view on EDGAR
- - Elizabeth S. Campbell view on EDGAR
- - Dennis M. Nally view on EDGAR
- - Ellen Cooper view on EDGAR
- - Lauren M. Tyler view on EDGAR
- - Silvana Battaglia view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Consumer Staples
- Where COR's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow COR with a 7-day demo
- COR on your watchlist
- Every COR Form 4 filing on record
- Up to 3 months of COR price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
